{"name": "Elusys Therapeutics",
 "permalink": "elusys-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/elusys-therapeutics",
 "homepage_url": "http://www.elusys.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@elusys.com",
 "phone_number": "973-808-0222",
 "description": "Biopharmaceutical company",
 "created_at": "Fri Aug 03 13:25:42 UTC 2012",
 "updated_at": "Sat Sep 15 03:35:22 UTC 2012",
 "overview": "\u003Cp\u003EElusys Therapeutics is a privately-held biopharmaceutical company focused on the development of antibody-based therapies for the treatment of infectious disease. The Company has pioneered the development of a rapid injection, anti-toxin antibody, Anthim\u00ae, for the prophylaxis and treatment of anthrax disease following a biowarfare attack. Anthim has consistently demonstrated significant efficacy in multiple non-clinical animal studies and has been successfully evaluated in two clinical safety trials.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       59],
      "assets/images/resized/0020/4233/204233v1-max-150x150.jpg"],
     [[189,
       75],
      "assets/images/resized/0020/4233/204233v1-max-250x250.jpg"],
     [[189,
       75],
      "assets/images/resized/0020/4233/204233v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Founder and CEO",
    "person":
     {"first_name": "Jeff",
      "last_name": "Wolf",
      "permalink": "jeff-wolf",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0026/8787/268787v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/8787/268787v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/8787/268787v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "scientific advisor ",
    "person":
     {"first_name": "Paul",
      "last_name": "Belsky",
      "permalink": "paul-belsky",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "25 Riverside Drive, Unit One",
    "address2": "",
    "zip_code": "07058",
    "city": "Pine Brook",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Elusys Receives $50M More Under Federal Contract for Anthrax Treatment",
    "stoned_year": 2012,
    "stoned_month": 8,
    "stoned_day": 2,
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020120802e882qpv9r\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120802e882qpv9r%26from%3dalert%26pid%3d32",
    "source_text": "",
    "source_description": "Elusys Receives $50M More Under Federal Contract for Anthrax Treatment",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Elusys Therapeutics",
      "permalink": "elusys-therapeutics"}},
   {"description": "NJ biotech wins $14.5M from U.S. gov't to study drug against anthrax",
    "stoned_year": 2012,
    "stoned_month": 9,
    "stoned_day": 14,
    "source_url": "http://www.fiercebiotech.com/story/nj-biotech-wins-145m-us-govt-study-drug-against-anthrax/2012-09-14?utm_source=rss\u0026utm_medium=rss",
    "source_text": "",
    "source_description": "NJ biotech wins $14.5M from U.S. gov't to study drug against anthrax",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Elusys Therapeutics",
      "permalink": "elusys-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        108],
       "assets/images/resized/0020/4234/204234v1-max-150x150.jpg"],
      [[250,
        180],
       "assets/images/resized/0020/4234/204234v1-max-250x250.jpg"],
      [[450,
        325],
       "assets/images/resized/0020/4234/204234v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}